Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 4.417
Filtrer
1.
Neuropharmacology ; 257: 110058, 2024 Oct 01.
Article de Anglais | MEDLINE | ID: mdl-38960135

RÉSUMÉ

Postnatal hippocampal neurogenesis is essential for learning and memory. Hippocampal neural precursor cells (NPCs) can be induced to proliferate and differentiate into either glial cells or dentate granule cells. Notably, hippocampal neurogenesis decreases dramatically with age, partly due to a reduction in the NPC pool and a decrease in their proliferative activity. Alpha-melanocyte-stimulating hormone (α-MSH) improves learning, memory, neuronal survival and plasticity. Here, we used postnatally-isolated hippocampal NPCs from Wistar rat pups (male and female combined) to determine the role of the melanocortin analog [Nle4, D-Phe7]-α-MSH (NDP-MSH) in proliferation and fate acquisition of NPCs. Incubation of growth-factor deprived NPCs with 10 nM NDP-MSH for 6 days increased the proportion of Ki-67- and 5-bromo-2'-deoxyuridine (BrdU)-positive cells, compared to the control group, and these effects were blocked by the MC4R antagonist JKC-363. NDP-MSH also increased the proportion of glial fibrillar acidic protein (GFAP)/Ki-67, GFAP/sex-determining region Y-box2 (SOX2) and neuroepithelial stem cell protein (NESTIN)/Ki-67-double positive cells (type-1 and type-2 precursors). Finally, NDP-MSH induced peroxisome proliferator-activated receptor (PPAR)-γ protein expression, and co-incubation with the PPAR-γ inhibitor GW9662 prevented the effect of NDP-MSH on NPC proliferation and differentiation. Our results indicate that in vitro activation of MC4R in growth-factor-deprived postnatal hippocampal NPCs induces proliferation and promotes the relative expansion of the type-1 and type-2 NPC pool through a PPAR-γ-dependent mechanism. These results shed new light on the mechanisms underlying the beneficial effects of melanocortins in hippocampal plasticity and provide evidence linking the MC4R and PPAR-γ pathways in modulation of hippocampal NPC proliferation and differentiation.


Sujet(s)
Différenciation cellulaire , Prolifération cellulaire , Hippocampe , Cellules souches neurales , Neurogenèse , Rat Wistar , Récepteur de la mélanocortine de type 4 , Hormone mélanotrope alpha , Animaux , Hippocampe/effets des médicaments et des substances chimiques , Hippocampe/métabolisme , Hippocampe/cytologie , Cellules souches neurales/effets des médicaments et des substances chimiques , Cellules souches neurales/métabolisme , Cellules souches neurales/physiologie , Prolifération cellulaire/effets des médicaments et des substances chimiques , Prolifération cellulaire/physiologie , Récepteur de la mélanocortine de type 4/métabolisme , Hormone mélanotrope alpha/pharmacologie , Hormone mélanotrope alpha/analogues et dérivés , Femelle , Différenciation cellulaire/effets des médicaments et des substances chimiques , Différenciation cellulaire/physiologie , Mâle , Neurogenèse/effets des médicaments et des substances chimiques , Neurogenèse/physiologie , Rats , Cellules cultivées , Facteurs de transcription SOX-B1/métabolisme , Animaux nouveau-nés , Protéine gliofibrillaire acide/métabolisme , Récepteur PPAR gamma/métabolisme
2.
Sci Rep ; 14(1): 15007, 2024 07 01.
Article de Anglais | MEDLINE | ID: mdl-38951654

RÉSUMÉ

Salivary gland squamous cell carcinomas (SG-SCCs) constitute a rare type of head and neck cancer which is linked to poor prognosis. Due to their low frequency, the molecular mechanisms responsible for their aggressiveness are poorly understood. In this work we studied the role of the phosphatase DUSP1, a negative regulator of MAPK activity, in controlling SG-SCC progression. We generated DUSP1 KO clones in A253 human cells. These clones showed a reduced ability to grow in 2D, self-renew in ECM matrices and to form tumors in immunodeficient mice. This was caused by an overactivation of the stress and apoptosis kinase JNK1/2 in DUSP1-/+ clones. Interestingly, RNAseq analysis revealed that the expression of SOX2, a well-known self-renewal gene was decreased at the mRNA and protein levels in DUSP1-/+ cells. Unexpectedly, CRISPR-KO of SOX2 did not recapitulate DUSP1-/+ phenotype, and SOX2-null cells had an enhanced ability to self-renew and to form tumors in mice. Gene expression analysis demonstrated that SOX2-null cells have a decreased squamous differentiation profile -losing TP63 expression- and an increased migratory phenotype, with an enhanced epithelial to mesenchymal transition signature. In summary, our data indicates that DUSP1 and SOX2 have opposite functions in SG-SCC, being DUSP1 necessary for tumor growth and SOX2 dispensable showing a tumor suppressor function. Our data suggest that the combined expression of SOX2 and DUSP1 could be a useful biomarker to predict progression in patients with SG-SCCs.


Sujet(s)
Carcinome épidermoïde , Évolution de la maladie , Dual Specificity Phosphatase 1 , Facteurs de transcription SOX-B1 , Tumeurs des glandes salivaires , Dual Specificity Phosphatase 1/métabolisme , Dual Specificity Phosphatase 1/génétique , Humains , Facteurs de transcription SOX-B1/génétique , Facteurs de transcription SOX-B1/métabolisme , Animaux , Souris , Tumeurs des glandes salivaires/génétique , Tumeurs des glandes salivaires/anatomopathologie , Tumeurs des glandes salivaires/métabolisme , Lignée cellulaire tumorale , Carcinome épidermoïde/génétique , Carcinome épidermoïde/anatomopathologie , Carcinome épidermoïde/métabolisme , Régulation de l'expression des gènes tumoraux , Prolifération cellulaire/génétique
3.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao ; 46(3): 329-333, 2024 Jun.
Article de Chinois | MEDLINE | ID: mdl-38953256

RÉSUMÉ

Objective To evaluate the value of SOX1 and PAX1 gene methylation detection in the secondary triage of high-grade cervical lesions.Methods Exfoliated cervical cells were collected from 122 patients tested positive for human papilloma virus (HPV) and subjected to thin-prep cytologic test (TCT) and SOX1/PAX1 gene methylation tests.Results The HPV test combined with TCT showed the sensitivity of 95.24% and the specificity of 23.75% for detecting cervical intraepithelial neoplasia (CIN) grade 2 and above (CIN2+).After the addition of the SOX1/PAX1 gene methylation detection in secondary triage,the sensitivity for detecting CIN2+ was 83.33%,which had no statistically significant difference from the sensitivity of TCT combined with HPV test (P=0.078).However,the specificity reached 77.50%,which was significantly higher than that of HPV test combined with TCT (P<0.001).The SOX1/PAX1 gene methylation level in the CIN2+ group was higher than those in the normal cervical tissue and the CIN1 group(P<0.001).The cut-off values of SOX1 and PAX1 gene methylation for CIN2+ detection were -11.81 and -11.98,respectively.Conclusion Adding the detection of SOX1/PAX1 gene methylation in secondary triage significantly improves the efficiency and accuracy of CIN2+ detection.


Sujet(s)
Méthylation de l'ADN , Facteurs de transcription PAX , Facteurs de transcription SOX-B1 , Dysplasie du col utérin , Tumeurs du col de l'utérus , Humains , Femelle , Facteurs de transcription PAX/génétique , Dysplasie du col utérin/génétique , Dysplasie du col utérin/diagnostic , Dysplasie du col utérin/virologie , Tumeurs du col de l'utérus/génétique , Tumeurs du col de l'utérus/diagnostic , Tumeurs du col de l'utérus/virologie , Facteurs de transcription SOX-B1/génétique , Adulte , Adulte d'âge moyen , Sensibilité et spécificité , Jeune adulte
4.
Cell Rep ; 43(7): 114446, 2024 Jul 23.
Article de Anglais | MEDLINE | ID: mdl-38996065

RÉSUMÉ

The gene encoding the NUAK family kinase 1 (NUAK1) is frequently amplified and its expression is upregulated, activating oncogenic signaling in various cancers. However, little is known about its role in gastric cancer (GC). We investigate the mechanistic links among NUAK1, Hedgehog signaling, and tumorigenesis in GC. NUAK1 overexpression is validated in local and public GC cohorts. Patient-derived xenograft and transgenic mouse models demonstrate that NUAK1 depletion or inhibition dramatically ameliorates gastric tumorigenesis. NUAK1 upregulates GLI1 expression by activating STAT5-mediated transcription and stabilizing GLI1 protein. NUAK1 depletion or inhibition impairs cancer cell expansion, tumor formation, and chemotherapy resistance in in vitro and in vivo models. Clinicopathological analysis confirms that upregulated NUAK1 expression correlates with poor prognosis and chemotherapy resistance in human GC. Our findings demonstrate that the signaling axis NUAK1/STAT5/GLI1 promotes cancer cell expansion and tumorigenesis and indicate that NUAK1 is an attractive therapeutic target and prognostic factor in GC.


Sujet(s)
Prolifération cellulaire , Résistance aux médicaments antinéoplasiques , Facteurs de transcription SOX-B1 , Facteur de transcription STAT-5 , Transduction du signal , Tumeurs de l'estomac , Protéine à doigt de zinc GLI1 , Tumeurs de l'estomac/anatomopathologie , Tumeurs de l'estomac/métabolisme , Tumeurs de l'estomac/génétique , Tumeurs de l'estomac/traitement médicamenteux , Humains , Protéine à doigt de zinc GLI1/métabolisme , Protéine à doigt de zinc GLI1/génétique , Résistance aux médicaments antinéoplasiques/génétique , Facteur de transcription STAT-5/métabolisme , Facteur de transcription STAT-5/génétique , Animaux , Lignée cellulaire tumorale , Souris , Prolifération cellulaire/effets des médicaments et des substances chimiques , Facteurs de transcription SOX-B1/métabolisme , Facteurs de transcription SOX-B1/génétique , Régulation de l'expression des gènes tumoraux , Souris nude , Protein-Serine-Threonine Kinases/métabolisme , Protein-Serine-Threonine Kinases/génétique , Mâle , Femelle , Carcinogenèse/anatomopathologie , Carcinogenèse/génétique
5.
Cancer Biol Ther ; 25(1): 2373447, 2024 Dec 31.
Article de Anglais | MEDLINE | ID: mdl-38975736

RÉSUMÉ

Lung squamous cell carcinoma (LSCC) is a deadly cancer in the world. Histone demethylase Jmjd2c is a key epigenetic regulator in various tumors, while the molecular mechanism underlying Jmjd2c regulatory in LSCC is still unclear. We used the aldehyde dehydrogenasebright (ALDHbri+) subtype as a research model for cancer stem cells (CSCs) in LSCC and detected the sphere formation ability and the proportion of ALDHbri+ CSCs with Jmjd2c interference and caffeic acid (CA) treatment. Additionally, we carried out bioinformatic analysis on the expression file of Jmjd2c RNAi mice and performed western blotting, qRT-PCR, Co-IP and GST pull-down assays to confirm the bioinformatic findings. Moreover, we generated Jmjd2c-silenced and Jmjd2c-SOX2-silenced ALDHbri+ tumor-bearing BALB/c nude mice to detect the effects on tumor progression. The results showed that Jmjd2c downregulation inhibited the sphere formation and the proportion of ALDHbri+ CSCs. The SOX2 decreased expression significantly in Jmjd2c RNAi mice, and they were positively co-expressed according to the bioinformatic analysis. In addition, SOX2 expression decreased in Jmjd2c shRNA ALDHbri+ CSCs, Jmjd2c and SOX2 proteins interacted with each other. Furthermore, Jmjd2c interference revealed significant blocking effect, and Jmjd2c-SOX2 interference contributed even stronger inhibition on ALDHbri+ tumor progression. The Jmjd2c and SOX2 levels were closely related to the development and prognosis of LSCC patients. This study indicated that Jmjd2c played key roles on maintaining ALDHbri+ CSC activity in LSCC by interacting with transcription factor SOX2. Jmjd2c might be a novel molecule for therapeutic targets and biomarkers in the diagnosis and clinical treatment of lung cancer.


Sujet(s)
Carcinome épidermoïde , Jumonji Domain-Containing Histone Demethylases , Tumeurs du poumon , Cellules souches tumorales , Facteurs de transcription SOX-B1 , Animaux , Femelle , Humains , Mâle , Souris , Carcinome épidermoïde/métabolisme , Carcinome épidermoïde/anatomopathologie , Carcinome épidermoïde/génétique , Lignée cellulaire tumorale , Régulation de l'expression des gènes tumoraux , Jumonji Domain-Containing Histone Demethylases/métabolisme , Jumonji Domain-Containing Histone Demethylases/génétique , Tumeurs du poumon/métabolisme , Tumeurs du poumon/anatomopathologie , Tumeurs du poumon/génétique , Tumeurs du poumon/traitement médicamenteux , Souris de lignée BALB C , Souris nude , Cellules souches tumorales/métabolisme , Cellules souches tumorales/anatomopathologie , Facteurs de transcription SOX-B1/métabolisme , Facteurs de transcription SOX-B1/génétique
6.
Int J Mol Sci ; 25(11)2024 May 30.
Article de Anglais | MEDLINE | ID: mdl-38892233

RÉSUMÉ

In this immunohistological study on the peripheral retina of 3-year-old beagle dogs, excised retina specimens were immunostained with antibodies against nestin, Oct4, Nanog, Sox2, CDX2, cytokeratin 18 (CK 18), RPE65, and YAP1, as well as hematoxylin and DAPI, two nuclear stains. Our findings revealed solitary cysts of various sizes in the inner retina. Intriguingly, a mass of small round cells with scant cytoplasms was observed in the cavity of small cysts, while many disorganized cells partially occupied the cavity of the large cysts. The small cysts were strongly positive for nestin, Oct4, Nanog, Sox2, CDX2, CK18, and YAP1. RPE65-positive cells were exclusively observed in the tissue surrounding the cysts. Since RPE65 is a specific marker of retinal pigment epithelial (RPE) cells, the surrounding cells of the peripheral cysts were presumably derived from RPE cells that migrated intraretinally. In the small cysts, intense positive staining for nestin, a marker of retinal stem cells, seemed to indicate that they were derived from retinal stem cells. The morphology and positive staining for markers of blastocyst and RPE cells indicated that the small cysts may have formed structures resembling the blastocyst, possibly caused by the interaction between retinal stem cells and migrated RPE cells.


Sujet(s)
Rétine , Épithélium pigmentaire de la rétine , Animaux , Chiens , Rétine/métabolisme , Épithélium pigmentaire de la rétine/métabolisme , Épithélium pigmentaire de la rétine/cytologie , Nestine/métabolisme , Blastocyste/métabolisme , Blastocyste/cytologie , Marqueurs biologiques/métabolisme , Facteurs de transcription SOX-B1/métabolisme , Cellules souches/métabolisme , Cellules souches/cytologie , Immunohistochimie , Maladies des chiens/métabolisme , Maladies des chiens/anatomopathologie
7.
Sci Rep ; 14(1): 13661, 2024 06 13.
Article de Anglais | MEDLINE | ID: mdl-38871732

RÉSUMÉ

Over the past decades, the immune responses have been suspected of participating in the mechanisms for epilepsy. To assess the immune related pathway in temporal lobe epilepsy (TLE), we explored the altered immune pathways in TLE patients with and without hippocampal sclerosis (HS). We analyzed RNA-seq data from 3 TLE-HS and 3 TLE-nonHS patients, including identification of differentially expressed RNA, function pathway enrichment, the protein-protein interaction network and construction of ceRNA regulatory network. We illustrated the immune related landscape of molecules and pathways on human TLE-HS. Also, we identified several differential immune related genes like HSP90AA1 and SOD1 in TLE-HS patients. Further ceRNA regulatory network analysis found SOX2-OT connected to miR-671-5p and upregulated the target gene SPP1 in TLE-HS patients. Also, we identified both SOX2-OT and SPP1 were significantly upregulated in five different databases including TLE-HS patients and animal models. Our findings established the first immune related genes and possible regulatory pathways in TLE-HS patients and animal models, which provided a novel insight into disease pathogenesis in both patients and animal models. The immune related SOX2-OT/miR-671-5p/SPP1 axis may be the potential therapeutic target for TLE-HS.


Sujet(s)
Épilepsie temporale , Réseaux de régulation génique , Sclérose de l'hippocampe , microARN , Facteurs de transcription SOX-B1 , Adulte , Animaux , Femelle , Humains , Mâle , Épilepsie temporale/génétique , Épilepsie temporale/immunologie , Épilepsie temporale/physiopathologie , Analyse de profil d'expression de gènes , Sclérose de l'hippocampe/immunologie , Sclérose de l'hippocampe/physiopathologie , microARN/génétique , microARN/métabolisme , Ostéopontine/génétique , Ostéopontine/métabolisme , Cartes d'interactions protéiques , Facteurs de transcription SOX-B1/génétique , Facteurs de transcription SOX-B1/métabolisme
8.
Cells ; 13(11)2024 May 29.
Article de Anglais | MEDLINE | ID: mdl-38891067

RÉSUMÉ

Rapid information processing in the central nervous system requires the myelination of axons by oligodendrocytes. The transcription factor Sox2 and its close relative Sox3 redundantly regulate the development of myelin-forming oligodendrocytes, but little is known about the underlying molecular mechanisms. Here, we characterized the expression profile of cultured oligodendroglial cells during early differentiation and identified Bcas1, Enpp6, Zfp488 and Nkx2.2 as major downregulated genes upon Sox2 and Sox3 deletion. An analysis of mice with oligodendrocyte-specific deletion of Sox2 and Sox3 validated all four genes as downstream targets in vivo. Additional functional assays identified regulatory regions in the vicinity of each gene that are responsive to and bind both Sox proteins. Bcas1, Enpp6, Zfp488 and Nkx2.2 therefore likely represent direct target genes and major effectors of Sox2 and Sox3. Considering the preferential expression and role of these genes in premyelinating oligodendrocytes, our findings suggest that Sox2 and Sox3 impact oligodendroglial development at the premyelinating stage with Bcas1, Enpp6, Zfp488 and Nkx2.2 as their major effectors.


Sujet(s)
Différenciation cellulaire , Homéoprotéine Nkx-2.2 , Oligodendroglie , Facteurs de transcription SOX-B1 , Facteurs de transcription , Animaux , Souris , Différenciation cellulaire/génétique , Régulation de l'expression des gènes au cours du développement , Protéines à homéodomaine/métabolisme , Protéines à homéodomaine/génétique , Oligodendroglie/métabolisme , Oligodendroglie/cytologie , Phosphodiesterases/métabolisme , Phosphodiesterases/génétique , Facteurs de transcription SOX-B1/métabolisme , Facteurs de transcription SOX-B1/génétique , Facteurs de transcription SOX-C/métabolisme , Facteurs de transcription SOX-C/génétique , Facteurs de transcription/métabolisme , Facteurs de transcription/génétique
9.
Nat Commun ; 15(1): 4963, 2024 Jun 11.
Article de Anglais | MEDLINE | ID: mdl-38862535

RÉSUMÉ

Image-based lineage tracing enables tissue turnover kinetics and lineage potentials of different adult cell populations to be investigated. Previously, we reported a genetic mouse model system, Red2Onco, which ectopically expressed mutated oncogenes together with red fluorescent proteins (RFP). This system enabled the expansion kinetics and neighboring effects of oncogenic clones to be dissected. We now report Red2Flpe-SCON: a mosaic knockout system that uses multicolor reporters to label both mutant and wild-type cells. We develop the Red2Flpe mouse line for red clone-specific Flpe expression, as well as the FRT-based SCON (Short Conditional IntrON) method to facilitate tunable conditional mosaic knockouts in mice. We use the Red2Flpe-SCON method to study Sox2 mutant clonal analysis in the esophageal epithelium of adult mice which reveal that the stem cell gene, Sox2, is less essential for adult stem cell maintenance itself, but rather for stem cell proliferation and differentiation.


Sujet(s)
Protéines luminescentes , Souris knockout , , Facteurs de transcription SOX-B1 , Animaux , Facteurs de transcription SOX-B1/génétique , Facteurs de transcription SOX-B1/métabolisme , Souris , Protéines luminescentes/génétique , Protéines luminescentes/métabolisme , Mosaïcisme , Différenciation cellulaire , Prolifération cellulaire/génétique , Oesophage/métabolisme , Oesophage/anatomopathologie , Lignage cellulaire/génétique , Introns/génétique , Femelle , Mâle
10.
Development ; 151(14)2024 Jul 15.
Article de Anglais | MEDLINE | ID: mdl-38940470

RÉSUMÉ

SoxB1 transcription factors (Sox2/3) are well known for their role in early neural fate specification in the embryo, but little is known about functional roles for SoxB1 factors in non-neural ectodermal cell types, such as the neural plate border (NPB). Using Xenopus laevis, we set out to determine whether SoxB1 transcription factors have a regulatory function in NPB formation. Here, we show that SoxB1 factors are necessary for NPB formation, and that prolonged SoxB1 factor activity blocks the transition from a NPB to a neural crest state. Using ChIP-seq, we demonstrate that Sox3 is enriched upstream of NPB genes in early NPB cells and in blastula stem cells. Depletion of SoxB1 factors in blastula stem cells results in downregulation of NPB genes. Finally, we identify Pou5f3 factors as potential Sox3 partners in regulating the formation of the NPB and show that their combined activity is needed for normal NPB gene expression. Together, these data identify a role for SoxB1 factors in the establishment and maintenance of the NPB, in part through partnership with Pou5f3 factors.


Sujet(s)
Régulation de l'expression des gènes au cours du développement , Crête neurale , Plaque neurale , Facteurs de transcription SOX-B1 , Protéines de Xénope , Xenopus laevis , Animaux , Plaque neurale/métabolisme , Plaque neurale/embryologie , Facteurs de transcription SOX-B1/métabolisme , Facteurs de transcription SOX-B1/génétique , Protéines de Xénope/métabolisme , Protéines de Xénope/génétique , Crête neurale/métabolisme , Crête neurale/cytologie , Blastula/métabolisme , Embryon non mammalien/métabolisme
11.
Genes (Basel) ; 15(6)2024 Jun 13.
Article de Anglais | MEDLINE | ID: mdl-38927713

RÉSUMÉ

Members of the SOX (SRY-related HMG box) family of transcription factors are crucial for embryonic development and cell fate determination. This review investigates the role of SOX3 in cancer, as aberrations in SOX3 expression have been implicated in several cancers, including osteosarcoma, breast, esophageal, endometrial, ovarian, gastric, hepatocellular carcinomas, glioblastoma, and leukemia. These dysregulations modulate key cancer outcomes such as apoptosis, epithelial-mesenchymal transition (EMT), invasion, migration, cell cycle, and proliferation, contributing to cancer development. SOX3 exhibits varied expression patterns correlated with clinicopathological parameters in diverse tumor types. This review aims to elucidate the nuanced role of SOX3 in tumorigenesis, correlating its expression with clinical and pathological characteristics in cancer patients and cellular modelsBy providing a comprehensive exploration of SOX3 involvement in cancer, this review underscores the multifaceted role of SOX3 across distinct tumor types. The complexity uncovered in SOX3 function emphasizes the need for further research to unravel its full potential in cancer therapeutics.


Sujet(s)
Carcinogenèse , Tumeurs , Humains , Tumeurs/génétique , Tumeurs/métabolisme , Tumeurs/anatomopathologie , Carcinogenèse/génétique , Transition épithélio-mésenchymateuse/génétique , Facteurs de transcription SOX-B1/génétique , Facteurs de transcription SOX-B1/métabolisme , Régulation de l'expression des gènes tumoraux , Animaux
12.
Biosci Rep ; 44(7)2024 Jul 31.
Article de Anglais | MEDLINE | ID: mdl-38864530

RÉSUMÉ

Tamoxifen (TAM) is a key player in estrogen receptor-positive (ER+) breast cancer (BC); however, ∼30% of patients experience relapse and a lower survival rate due to TAM resistance. TAM resistance was related to the over expression of SOX-2 gene, which is regulated by the E2F3 transcription factor in the Wnt signaling pathway. It was suggested that SOX-2 overexpression was suppressed by dexamethasone (DEX), a glucocorticoid commonly prescribed to BC patients. The aim of the present study is to explore the effect of combining DEX and TAM on the inhibition of TAM-resistant LCC-2 cells (TAMR-1) through modulating the E2F3/SOX-2-mediated Wnt signaling pathway. The effect of the combination therapy on MCF-7 and TAMR-1 cell viability was assessed. Drug interactions were analyzed using CompuSyn and SynergyFinder softwares. Cell cycle distribution, apoptotic protein expression, gene expression levels of SOX-2 and E2F3, and cell migration were also assessed. Combining DEX with TAM led to synergistic inhibition of TAMR-1 cell proliferation and migration, induced apoptosis, reduced SOX-2 and E2F3 expression and was also associated with S and G2-M phase arrest. Therefore, combining DEX with TAM may present an effective therapeutic option to overcome TAM resistance, by targeting the E2F3/SOX-2/Wnt signaling pathway, in addition to its anti-inflammatory effect.


Sujet(s)
Tumeurs du sein , Prolifération cellulaire , Dexaméthasone , Résistance aux médicaments antinéoplasiques , Synergie des médicaments , Tamoxifène , Humains , Tamoxifène/pharmacologie , Dexaméthasone/pharmacologie , Résistance aux médicaments antinéoplasiques/effets des médicaments et des substances chimiques , Tumeurs du sein/traitement médicamenteux , Tumeurs du sein/métabolisme , Tumeurs du sein/anatomopathologie , Tumeurs du sein/génétique , Femelle , Cellules MCF-7 , Prolifération cellulaire/effets des médicaments et des substances chimiques , Apoptose/effets des médicaments et des substances chimiques , Mouvement cellulaire/effets des médicaments et des substances chimiques , Voie de signalisation Wnt/effets des médicaments et des substances chimiques , Régulation de l'expression des gènes tumoraux/effets des médicaments et des substances chimiques , Antinéoplasiques hormonaux/pharmacologie , Protocoles de polychimiothérapie antinéoplasique/pharmacologie , Lignée cellulaire tumorale , Facteur de transcription E2F3/métabolisme , Facteur de transcription E2F3/génétique , Facteurs de transcription SOX-B1/métabolisme , Facteurs de transcription SOX-B1/génétique
13.
In Vivo ; 38(4): 1767-1774, 2024.
Article de Anglais | MEDLINE | ID: mdl-38936924

RÉSUMÉ

BACKGROUND/AIM: Dermal papilla (DP) stem cells are known for their remarkable regenerative capacity, making them a valuable model for assessing the effects of natural products on cellular processes, including stemness, and autophagy. MATERIALS AND METHODS: Autophagy and stemness characteristics were assessed using real-time RT-PCR to analyze mRNA levels, along with immunofluorescence and western blot techniques for protein level evaluation. RESULTS: Butterfly Pea, Emblica Fruits, Kaffir Lime, and Thunbergia Laurifolia extracts induced autophagy in DP cells. Kaffir Lime-treated cells exhibited increase in the OCT4, NANOG, and SOX2 mRNA (6-, 5, and 5.5-fold, respectively), and protein levels (4-, 3-, and 1.5-fold, respectively). All extracts activated the survival protein kinase B (Akt) in DP cells. CONCLUSION: Natural products are a promising source for promoting hair growth by rejuvenating hair stem cells.


Sujet(s)
Autophagie , Produits biologiques , Follicule pileux , Extraits de plantes , Cellules souches , Autophagie/effets des médicaments et des substances chimiques , Humains , Cellules souches/effets des médicaments et des substances chimiques , Cellules souches/métabolisme , Cellules souches/cytologie , Produits biologiques/pharmacologie , Extraits de plantes/pharmacologie , Follicule pileux/effets des médicaments et des substances chimiques , Follicule pileux/cytologie , Facteur de transcription Oct-3/génétique , Facteur de transcription Oct-3/métabolisme , Protéine homéotique Nanog/métabolisme , Protéine homéotique Nanog/génétique , Facteurs de transcription SOX-B1/métabolisme , Facteurs de transcription SOX-B1/génétique , Protéines proto-oncogènes c-akt/métabolisme , Derme/cytologie , Derme/effets des médicaments et des substances chimiques , Derme/métabolisme , Différenciation cellulaire/effets des médicaments et des substances chimiques
14.
Funct Integr Genomics ; 24(3): 103, 2024 May 17.
Article de Anglais | MEDLINE | ID: mdl-38913281

RÉSUMÉ

Breast cancer severely affects women health. 70% of breast cancer are estrogen receptor positive. Breast cancer stem cells are a group of tumor with plasticity, causing tumor relapse and metastasis. RUNX3 is a tumor suppressor frequently inactivated in estrogen receptor positive breast cancer. However, the mechanism of how RUNX3 is involved in the regualation of cancer stem cell traits in estrogen receptor positive breast cancer remains elusive. In this study, we utilized cut-tag assay to investigate the binding profile RUNX3 in BT474 and T47D cell, and confirmed EXOSC4 as the bona-fide target of RUNX3; RUNX3 could bind to the promoter are of EXOSC4 to suppress its expression. Furthermore, EXOSC4 could increase the colony formation, cell invasion and mammosphere formation ability of breast cancer cells and upregulate the the expression of SOX2 and ALDH1. Consistent with these findings, EXOSC4 was associated with poorer survival for Luminal B/Her2 breast cancer patiens. At last, we confirmed that EXOSC4 mediated the tumor suppressive role of RUNX3 in breast cancer cells. In conclusion, we demonstrate that RUNX3 directly binds to the promoter region of EXOSC4, leading to the suppression of EXOSC4 expression and exerting a tumor-suppressive effect in estrogen receptor postivive breast cancer cells.


Sujet(s)
Tumeurs du sein , Sous-unité alpha 3 du facteur CBF , Régions promotrices (génétique) , Femelle , Humains , Aldéhyde déshydrogénase-1/métabolisme , Aldéhyde déshydrogénase-1/génétique , Tumeurs du sein/génétique , Tumeurs du sein/métabolisme , Tumeurs du sein/anatomopathologie , Lignée cellulaire tumorale , Sous-unité alpha 3 du facteur CBF/génétique , Sous-unité alpha 3 du facteur CBF/métabolisme , Régulation de l'expression des gènes tumoraux , Cellules souches tumorales/métabolisme , Cellules souches tumorales/anatomopathologie , Retinal dehydrogenase/métabolisme , Retinal dehydrogenase/génétique , Facteurs de transcription SOX-B1/métabolisme , Facteurs de transcription SOX-B1/génétique
15.
Sci Rep ; 14(1): 14900, 2024 06 28.
Article de Anglais | MEDLINE | ID: mdl-38942903

RÉSUMÉ

Eukaryotic cells can synthesize formyl-methionine (fMet)-containing proteins not only in mitochondria but also in the cytosol to some extent. Our previous study revealed substantial upregulation of N-terminal (Nt)-fMet-containing proteins in the cytosol of SW480 colorectal cancer cells. However, the functional and pathophysiological implications remain unclear. Here, we demonstrated that removal of the Nt-formyl moiety of Nt-fMet-containing proteins (via expressing Escherichia coli PDF peptide deformylase) resulted in a dramatic increase in the proliferation of SW480 colorectal cancer cells. This proliferation coincided with the acquisition of cancer stem cell features, including reduced cell size, enhanced self-renewal capacity, and elevated levels of the cancer stem cell surface marker CD24 and pluripotent transcription factor SOX2. Furthermore, deformylation of Nt-fMet-containing proteins promoted the tumorigenicity of SW480 colorectal cancer cells in an in vivo xenograft mouse model. Taken together, these findings suggest that cytosolic deformylation has a tumor-enhancing effect, highlighting its therapeutic potential for cancer treatment.


Sujet(s)
Amidohydrolases , Prolifération cellulaire , Cytosol , Cellules souches tumorales , Humains , Cellules souches tumorales/métabolisme , Cellules souches tumorales/anatomopathologie , Animaux , Cytosol/métabolisme , Souris , Lignée cellulaire tumorale , Amidohydrolases/métabolisme , Tumeurs colorectales/métabolisme , Tumeurs colorectales/anatomopathologie , Antigènes CD24/métabolisme , Facteurs de transcription SOX-B1/métabolisme , Évolution de la maladie , Méthionine/métabolisme , Méthionine/analogues et dérivés
16.
J Med Virol ; 96(5): e29521, 2024 May.
Article de Anglais | MEDLINE | ID: mdl-38727013

RÉSUMÉ

Methylation panels, tools for investigating epigenetic changes associated with diseases like cancer, can identify DNA methylation patterns indicative of disease, providing diagnostic or prognostic insights. However, the application of methylation panels focusing on the sex-determining region Y-box 1 (SOX1) and paired box gene 1 (PAX1) genes for diagnosing cervical lesions is under-researched. This study aims to examine the diagnostic performance of PAX1/SOX1 gene methylation as a marker for cervical precancerous lesions and its potential application in triage diagnosis. From September 2022 to April 2023, 181 patients with abnormal HPV-DNA tests or cytological exam results requiring colposcopy were studied at Hubei Maternal and Child Health Hospital, China. Data were collected from colposcopy, cytology, HPV-DNA tests, and PAX1/SOX1 methylation detection. Patients were categorized as control, cervical intraepithelial neoplasia Grade 1 (CIN1), Grade 2 (CIN2), Grade 3 (CIN3), and cervical cancer (CC) groups based on histopathology. We performed HPV testing, liquid-based cytology, and PAX1/SOX1 gene methylation testing. We evaluated the diagnostic value of methylation detection in cervical cancer using DNA methylation positivity rate, sensitivity, specificity, and area under the curve (AUC), and explored its potential for triage diagnosis. PAX1/SOX1 methylation positivity rates were: control 17.1%, CIN1 22.5%, CIN2 100.0%, CIN3 90.0%, and CC 100.0%. The AUC values for PAX1 gene methylation detection in diagnosing CIN1+, CIN2+, and CIN3+ were 0.52 (95% confidence interval [CI]: 0.43-0.62), 0.88 (95% CI: 0.80-0.97), and 0.88 (95% CI: 0.75-1.00), respectively. Corresponding AUC values for SOX1 gene methylation detection were 0.47 (95% CI: 0.40-0.58), 0.80 (95% CI: 0.68-0.93), and 0.92 (95% CI: 0.811-1.00), respectively. In HPV16/18-negative patients, methylation detection showed sensitivity of 32.4% and specificity of 83.7% for CIN1+. For CIN2+ and CIN3+, sensitivity was all 100%, with specificities of 83.0% and 81.1%. Among the patients who underwent colposcopy examination, 166 cases had cytological examination results ≤ASCUS, of which 37 cases were positive for methylation, and the colposcopy referral rate was 22.29%. PAX1/SOX1 gene methylation detection exhibits strong diagnostic efficacy for cervical precancerous lesions and holds significant value in triage diagnosis.


Sujet(s)
Méthylation de l'ADN , Facteurs de transcription PAX , Infections à papillomavirus , Facteurs de transcription SOX-B1 , Dysplasie du col utérin , Tumeurs du col de l'utérus , Adulte , Femelle , Humains , Adulte d'âge moyen , Jeune adulte , Marqueurs biologiques tumoraux/génétique , Chine , Colposcopie , Dépistage précoce du cancer/méthodes , Facteurs de transcription PAX/génétique , Infections à papillomavirus/diagnostic , Infections à papillomavirus/virologie , Infections à papillomavirus/génétique , États précancéreux/diagnostic , États précancéreux/génétique , Sensibilité et spécificité , Facteurs de transcription SOX-B1/génétique , Triage/méthodes , Dysplasie du col utérin/diagnostic , Dysplasie du col utérin/génétique , Dysplasie du col utérin/virologie , Tumeurs du col de l'utérus/diagnostic , Tumeurs du col de l'utérus/génétique
17.
Mol Genet Genomics ; 299(1): 53, 2024 May 16.
Article de Anglais | MEDLINE | ID: mdl-38753163

RÉSUMÉ

SoxB subfamily is an important branch of Sox family and plays a key role in animal physiological process, but little is known about their function in planarian regeneration. This study aims to evaluate the function of DjSoxB family genes in intact and regenerating planarians Dugesia japonica. Here, we amplify the full-length cDNA of DjSoxB1 and DjSoxB2 in D. japonica by rapid amplification of the cDNA ends (RACE), detect the expression of DjSoxB family genes in planarian. The results show that DjSoxBs are expressed in parenchymal tissue and the hybridization signals partially disappear after irradiation indicates DjSoxB family genes are expressed in neoblasts. After the RNA interference (RNAi) of DjSoxB1, DjSoxB2 and DjSoxB3 separately, the numbers of proliferative cells are all reduced that causes planarians show slower growth of blastema in the early stage of regeneration, and nerves of planarians are affected that the movement speed of planarians decreases in varying degrees. Specially, planarians in the DjSoxB3 RNAi group show shrinkage and twisting. Overall, this study reveals that DjSoxB family genes play a role in cell proliferation during regeneration. They also play an important role in the maintenance of normal nerve function and nerve regeneration. These results provide directions for the functional study of SoxB family genes and provide an important foundation for planarian regeneration.


Sujet(s)
Planaires , Régénération , Animaux , Planaires/génétique , Planaires/physiologie , Régénération/génétique , Interférence par ARN , Prolifération cellulaire/génétique , Protéines d'helminthes/génétique , Protéines d'helminthes/métabolisme , Facteurs de transcription SOX-B1/génétique
18.
Stem Cell Reports ; 19(5): 710-728, 2024 May 14.
Article de Anglais | MEDLINE | ID: mdl-38701780

RÉSUMÉ

Heterogeneity among both primed and naive pluripotent stem cell lines remains a major unresolved problem. Here we show that expressing the maternal-specific linker histone H1FOO fused to a destabilizing domain (H1FOO-DD), together with OCT4, SOX2, KLF4, and LMYC, in human somatic cells improves the quality of reprogramming to both primed and naive pluripotency. H1FOO-DD expression was associated with altered chromatin accessibility around pluripotency genes and with suppression of the innate immune response. Notably, H1FOO-DD generates naive induced pluripotent stem cells with lower variation in transcriptome and methylome among clones and a more uniform and superior differentiation potency. Furthermore, we elucidated that upregulation of FKBP1A, driven by these five factors, plays a key role in H1FOO-DD-mediated reprogramming.


Sujet(s)
Reprogrammation cellulaire , Histone , Cellules souches pluripotentes induites , Facteur-4 de type Kruppel , Reprogrammation cellulaire/génétique , Humains , Cellules souches pluripotentes induites/cytologie , Cellules souches pluripotentes induites/métabolisme , Histone/métabolisme , Différenciation cellulaire/génétique , Facteurs de transcription Krüppel-like/métabolisme , Facteurs de transcription Krüppel-like/génétique , Facteurs de transcription SOX-B1/métabolisme , Facteurs de transcription SOX-B1/génétique , Chromatine/métabolisme , Cellules souches pluripotentes/métabolisme , Cellules souches pluripotentes/cytologie , Facteurs de transcription/métabolisme , Facteurs de transcription/génétique , Transcriptome
19.
Sci Rep ; 14(1): 11013, 2024 05 14.
Article de Anglais | MEDLINE | ID: mdl-38745039

RÉSUMÉ

Cancer Stem Cells presumably drive tumor growth and resistance to conventional cancer treatments. From a previous computational model, we inferred that these cells are not uniformly distributed in the bulk of a tumorsphere. To confirm this result, we cultivated tumorspheres enriched in stem cells, and performed immunofluorescent detection of the stemness marker SOX2 using confocal microscopy. In this article, we present an image processing method that reconstructs the amount and location of the Cancer Stem Cells in the spheroids. Its advantage is the use of a statistical criterion to classify the cells in Stem and Differentiated, instead of setting an arbitrary threshold. Moreover, the analysis of the experimental images presented in this work agrees with the results from our computational models, thus enforcing the notion that the distribution of Cancer Stem Cells in a tumorsphere is non-homogeneous. Additionally, the method presented here provides a useful tool for analyzing any image in which different kinds of cells are stained with different markers.


Sujet(s)
Cellules souches tumorales , Sphéroïdes de cellules , Cellules souches tumorales/métabolisme , Cellules souches tumorales/anatomopathologie , Humains , Sphéroïdes de cellules/anatomopathologie , Sphéroïdes de cellules/métabolisme , Facteurs de transcription SOX-B1/métabolisme , Traitement d'image par ordinateur/méthodes , Microscopie confocale , Lignée cellulaire tumorale
20.
BMC Pulm Med ; 24(1): 250, 2024 May 21.
Article de Anglais | MEDLINE | ID: mdl-38773432

RÉSUMÉ

BACKGROUND: This study assessed the diagnosis, staging and treatment guidance of lung cancer (LC) based on seven tumor-associated autoantibodies (TAAbs) -p53, PGP9.5, SOX2, GBU4-5, MAGE A1, CAGE, and GAGE7. METHODS: ELISA was used to determine the TAAb serum levels in 433 patients diagnosed with LC (161 surgical patients) and 76 patients with benign lung disease (16 surgical patients). The statistical characteristic of the TAAbs was compared among patients with different clinicopathological features. Pre- to postoperative changes in TAAb levels were analyzed to determine their value of LC. RESULTS: Among all patients, the positive rate of the seven TAAbs was 23.4%, sensitivity was 26.3%, accuracy was 36.3%, specificity was 93.4%, positive predictive value was 95.8%, and negative predictive value was 18.2%; the positive rate for the LC group (26.3%) was significantly higher than that for the benign group (6.6%; P < 0.001). Significant differences in the positive rate of the seven autoantibodies according to age (P < 0.001), smoking history (P = 0.009) and clinical LC stage (P < 0.001) were found. Smoking was positively associated with the positive of TAAbs (Τ = 0.118, P = 0.008). The positive rates of the seven TAAbs for squamous carcinoma (54.5%), other pathological types (44.4%) and poorly differentiated LC (57.1%) were significantly higher than those for the other types. The positive rate of GBU4-5 was highest among all TAAbs, and the SOX2 level in stage III-IV patients was much higher than that in other stages. For patients undergoing surgery, compared with the preoperative levels, the postoperative levels of the 7 markers, particularly p53 (P = 0.027), PGP9.5 (P = 0.007), GAGE7 (P = 0.014), and GBU4-5 (P = 0.002), were significantly different in the malignant group, especially in stage I-II patients, while no clear pre- to postoperative difference was observed in the benign group. CONCLUSIONS: When the seven TAAbs was positive, it was very helpful for the diagnosis of LC. The 7 TAAbs was valuable for staging and guiding treatment of LC in surgical patients.


Sujet(s)
Autoanticorps , Marqueurs biologiques tumoraux , Tumeurs du poumon , Stadification tumorale , Humains , Tumeurs du poumon/immunologie , Tumeurs du poumon/anatomopathologie , Tumeurs du poumon/diagnostic , Tumeurs du poumon/sang , Autoanticorps/sang , Mâle , Femelle , Adulte d'âge moyen , Sujet âgé , Marqueurs biologiques tumoraux/sang , Adulte , Facteurs de transcription SOX-B1/immunologie , Sensibilité et spécificité , Protéine p53 suppresseur de tumeur/immunologie , Test ELISA , Sujet âgé de 80 ans ou plus , Carcinome épidermoïde/immunologie , Carcinome épidermoïde/sang , Carcinome épidermoïde/diagnostic , Carcinome épidermoïde/anatomopathologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE